Geobacillus stearothermophilus 6-phosphogluconate dehydrogenase complexed with 6-phosphogluconate

Area of Science:

• Biochemistry
• Structural Biology
• Enzymology

Background:

• 6-phosphogluconate dehydrogenase (6PDH) is crucial in various metabolic pathways.
• The protozoan parasite Trypanosoma brucei 6PDH is a potential drug target for African sleeping sickness.
• Structural data for T. brucei 6PDH is limited, hindering inhibitor development.

Purpose of the Study:

• To determine the crystal structures of recombinant Geobacillus stearothermophilus 6-phosphogluconate dehydrogenase (Gs6PDH) complexed with its substrate.
• To compare the structure of Gs6PDH with homologous enzymes, particularly T. brucei 6PDH.
• To evaluate Gs6PDH as a potential surrogate model for structure-based drug design.

Main Methods:

• X-ray crystallography was used to determine the 3D structures of Gs6PDH.
• Medium-resolution crystal structures were obtained for Gs6PDH in complex with 6-phosphogluconate.
• Bioinformatic tools were used for sequence and structural comparisons.

Main Results:

• Two crystal structures of Gs6PDH with 6-phosphogluconate were solved at medium resolution.
• Gs6PDH exhibits significant sequence and structural similarity to other 6PDH enzymes, including T. brucei.
• Highly conserved active-site residues and substrate-binding interactions were observed.

Conclusions:

• Gs6PDH shares key structural features with T. brucei 6PDH, especially in the active site.
• The structural conservation suggests Gs6PDH can be a valuable model for studying 6PDH inhibitors.
• Gs6PDH's efficient expression and crystallization properties make it suitable for structure-based inhibitor design against Trypanosoma species.